Prospective evaluation of EBUS-TBNA specimens for programmed death-ligand 1 expression in non-small cell lung cancer patients: a pilot study

Guarize, Juliana; Rocco, Elena Guerini; Marinis, Filippo de; Sedda, Giulia; Bertolaccini, Luca; Donghi, Stefano Maria; Casiraghi, Monica; Tonno, Clementina Di; Barberis, Massimo; Spaggiari, Lorenzo.
J. bras. pneumol ; 47(4): e20200584, 2021. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1279298

Documentos relacionados

  1. Endobronchial Ultrasound Guided Transbronchial Needle Aspiration and PD-L1 Yields.
  2. Prospective evaluation of EBUS-TBNA specimens for programmed death-ligand 1 expression in non-small cell lung cancer patients: a pilot study.
  3. PD-L1 Expression is not a Predictive Factor for Recurrence in Resected Non-small Cell Lung Cancer.
  4. Organ-specific metastatic landscape dissects PD-(L)1 blockade efficacy in advanced non-small cell lung cancer: applicability from clinical trials to real-world practice.
  5. Diagnostic yield of endobronchial ultrasound-guided transbronchial needle aspiration to assess tumor-programmed cell death ligand-1 expression in mediastinal lymph nodes metastasized from non-small cell lung cancer.
  6. Expression of PD-L1 correlates with pleomorphic morphology and histological patterns of non-small-cell lung carcinomas.
  7. Effects of TRPV2 on the Expression of PD-L1 and Its Binding Ability to PD-1 in Gastric Cancer.
  8. Circulating tumour cells and PD-L1-positive small extracellular vesicles: the liquid biopsy combination for prognostic information in patients with metastatic non-small cell lung cancer.
  9. Reliable Detection of Extracellular PD-L1 by DNA Computation-Mediated Microfluidics.
  10. Polymorphisms of the PD-L1 gene 3'-untranslated region are associated with the expression of PD-L1 in non-small cell lung cancer.